Skip to content

Perspective Therapeutics CATX Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$887K-26.2%
Immunome logo
ImmunomeIMNM
$5.1M+199%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$2.33M+919%
Precigen logo
PrecigenPGEN
$562K+1,322%
Zymeworks logo
ZymeworksZYME
$1.73M+160%
Eli Lilly logo
Eli LillyLLY

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$28.3M-29.5%
Net income-$26.2M-44.1%
EPS (diluted)-$0.250.0%

Balance sheet

See full
Cash & equivalents$54.0M+21.5%
Total debt$4.2M+10.9%
Total equity$347.4M+22.1%
Total assets$410.8M+24.7%

Cash flow

See full
Operating cash flow-$31.5M-45.8%
CapEx$6.9M+47.3%
Free cash flow-$38.3M-46.1%

Valuation

See full
Market cap$342.14M+33.2%
Enterprise value$292.34M+35.2%
P/S34.2×+19.6×

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp
FCF margin-1,073.3%

Returns & leverage

See full
Return on equity-35.2%+2.3pp
Debt / equity0.0×
Current ratio8.7×-8.3×

Where this comes from

Reported directly by Perspective Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perspective Therapeutics's increase (decrease) in prepaid expense and other assets?
Perspective Therapeutics (CATX) reported increase (decrease) in prepaid expense and other assets of $327K in Q1 2026.
How has Perspective Therapeutics's increase (decrease) in prepaid expense and other assets changed year-over-year?
Perspective Therapeutics's increase (decrease) in prepaid expense and other assets increased by 236.2% year-over-year, from -$240K to $327K.
What is the long-term trend for Perspective Therapeutics's increase (decrease) in prepaid expense and other assets?
Over 3 years (2022 to 2025), Perspective Therapeutics's increase (decrease) in prepaid expense and other assets has grown at a 47.4% compound annual growth rate (CAGR), from $198K to -$634K.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.